Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
Crossref DOI link: https://doi.org/10.1007/s10096-015-2472-0
Published Online: 2015-09-25
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rubio-Terrés, C.
Cobo Reinoso, J.
Grau Cerrato, S.
Mensa Pueyo, J.
Salavert Lletí, M.
Toledo, A.
Anguita, P.
Rubio-Rodríguez, D.
Watt, M.
Gani, R.
Text and Data Mining valid from 2015-09-25